Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent

Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent

US Patent 8927530 · Granted Jan 6, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Asymmetric process for the preparation of thieno-indoles derivatives2020
Asymmetric process for the preparation of thieno-indoles derivatives2019
Thieno-indole moieties and methods of treating using the same2018
Morpholinyl anthracycline derivatives2017
Anthracycline derivative conjugates, process for their preparation and their use2017
Anthracycline derivative conjugates, process for their preparation and their use2017
Functionalized thieno-indole derivatives for the treatment of cancer2017
Functionalized 9-bromo-camptothecin derivatives2017
Thieno-indole moieties and methods of treating using the same2016
Isoxazolo-quinazolines as modulators of protein kinase activity2016
Tricyclic pyrrolo derivatives, process for their preparation and their use as ki2016
Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent2015